Autologous Fat Grafting Beneath Penile Split Thickness Skin Graft Placement During Penile Reconstruction

April 28, 2026 updated by: Paul Rusilko, University of Pittsburgh

Assessing Possible Improvements to Cosmetic and Functional Outcomes of Penile Split Thickness Skin Grafting With Autologous Fat Graft

The goal of this randomized interventional clinical trial is to learn if placement of a thin layer of fatty tissue (fat graft) beneath a split-thickness skin graft on the surface of the penis improved outcomes of surgery in men who are scheduled to undergo reconstructive surgery on their penis and genitals. This is a randomized study, meaning that half of participants will receive the fat graft with their standard-of-care surgery, and half will have their standard-of-care surgery alone. Fat grafting underneath split-thickness skin grafts in other parts of the body has been shown to improve healing of the skin graft. Both study groups will be followed for specific outcomes through outpatient clinic visits for the first 12 months after their surgery, as well as chart review.

Questions the investigators hope to answer include:

  • Does fat grafting improve the pliability and feel of the penile skin after grafting
  • Does fat grafting change the penile length after surgery
  • Does fat grafting improve sexual function, urinary function, and genital self-image after surgery
  • Are there any unforeseen complications related to the fat grafting procedure

Participants will be asked to complete questionnaires related to sexual, urinary, and genital self-image questionnaires before surgery, 3 months after surgery, and 12 months after surgery. Noninvasive testing of the penile skin will also be performed at participants' routine appointments.

Study Overview

Detailed Description

The investigators seek to study a novel adipose-based therapeutic strategy to improve cosmetic and function outcomes at the time of penile split-thickness skin graft (STSG) application during penile reconstruction. This entails a therapeutic repurposing of commonly utilized fat and skin grafting protocols to provide a fat-first reconstruction to address each of these limitations in one simple, economical, and widely accessible treatment for point-of-care penile reconstruction. Autologous adipose tissue is ideal as an adjunct to penile split-thickness skin grafting because it: 1) provides immediate, biologic soft tissue coverage with minimal to no donor site burden; 2) remains viable in poorly vascularized wound beds and can be placed as a biologic dressing without specialized microsurgical care; 3) enhances angiogenesis to mitigate risk of infection of deeper structures; 4) mitigates adhesions to underlying structures; and 5) can be used as immediate platform for rapid restoration of cutaneous integrity. By leveraging these techniques, the investigators seek to provide a safe, effective, and available option to augment standard-of-care reconstruction techniques.

Multiple conditions can lead to a need for penile reconstruction. Penile trauma, including burns, penetrating injury, blast injury, and friction injury can irreversibly damage penile skin, leading to a need to resurface the shaft and/or glans of the penis with local tissue flaps or autologous grafts. Infectious processes, most notably Fournier's gangrene, can also lead to loss of penile skin. Finally, adult-acquired buried penis (AABP) disease, a condition wherein the penis becomes trapped by adjacent soft tissues leading to chronic inflammation and loss of penile epithelial integrity, can require surgical excision of penile skin as part of a multicomponent repair. In all of these cases, STSG of the penile shaft is considered standard of care if local flaps, such as scrotal flaps, are not available for reconstruction due to overlapping disease processes. STSGs are commonly utilized to allow for rapid, definitive closure and restoration of the integument.

While STSG graft take on the penis following these processes is successful >95% of the time with restoration of urinary outcomes, patients who have undergone the procedure typically report dissatisfaction with the cosmetic appearance of their penile skin. This is due to adhesion of the STSG to the fixed Buck's deep fascia of the penis, which occurs due to the loss of the mobile Dartos fascia during the time of initial insult/injury. The combination of adhesion and graft contracture/fibrosis can lead to a "plasticky" feeling of the penile skin, which is especially bothersome given the expansile nature of the deep cavernosal bodies during sexual arousal. While current sexual outcomes in patients undergoing penile reconstruction are superior to patients who do not undergo reconstruction, there exists significant room for improvement. There currently exist no off-the-shelf products with proven efficacy in improving outcomes.

Adipose tissue is a prime candidate for this application due to its autologous origin, ease of procurement with minimal-to-no additional donor site morbidity, and abundant availability in patients, alongside its unique reconstructive and regenerative capacities. The use of autologous adipose in delayed tissue reconstruction is well established. However, the full therapeutic potential of adipose tissue remains underexploited. Fat grafting provides immediate soft tissue bulk, enhances angiogenesis, is both immunomodulatory and enhances immunologic homing, and supplies mesenchymal cells for soft tissue healing. Fat grafting is viable in hostile recipient beds including infected/contaminated and poorly vascularized wounds such as the diabetic foot ulcer, irradiated skin, and burn scars.

Grafting of autologous fat tissue is a minimally invasive surgical technique that starts with the harvest of small particles (2-5 mm) of fat tissue from the abdomen or using liposuction. Sometimes, fat graft can be harvested from tissue that is removed for other reasons. This technique utilizes incisions smaller than 5 mm in length and rapid intraoperative processing allowing for immediate transplantation of a patient's own tissue in a single operative procedure. Autologous fat can also be obtained from adipose tissue removed intraoperatively, which is a standard component to AABP repair, and processed intraoperatively for immediate use. This follows a standard fat grafting preparation protocol currently being used for standard of care cases.

A multitude of data exist to support the utility of autologous fat grafting for other disease processes at a variety of anatomic sites. Applications that have been subject to rigorous prior study include:

  • Improvement in soft tissue volume, pliability, and skin quality after autologous fat grafting of atrophic amputation stumps
  • Improvement in tissue pliability in a porcine burn model
  • Improvement in human burn patients when autologous fat grafting was performed beneath a STSG overlying tendon in a burn patient

In the study described herein, participants will undergo the standard-of-care baseline reconstructive surgery for their primary disease process. This will include any necessary debridement, penile degloving, and soft tissue excision of the penis, genitals, and surrounding tissues as indicated by their primary traumatic, infectious, or other disease process. Post-operative wound care will proceed along standard-of-care pathways and will not be altered for the purposes of this protocol.

It is important to recognize that no cell extraction or isolation will be performed in this trial. The fat graft is regulated as a standard surgical procedure with no more than minimal manipulation of the fat tissue. Fat graft injection has been widely adopted by plastic surgeons, dermatologists, and ophthalmologists in clinical practice. Because these are autologous fat grafts that undergo minimal manipulation, they are regulated as a standard surgical procedure and are well-tolerated by patients with minimal safety risks. Only simple processing will be performed with the fat tissue to improve its texture and compliance as is already the standard of care and commonly performed. As autologous fat grafting is well known to soften scarring from trauma, surgical manipulation/incisions, and radiation fibrosis, the investigators believe this approach will be efficacious and well-tolerated due to the common anatomic factors seen in the penis and other parts of the body.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15219
        • UPMC Mercy Hospital
        • Sub-Investigator:
          • Patsy Simon, BS, RN, CCRC, CCRA, ACRP-PM
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ability to participate in informed consent
  • Loss of penile skin necessitating split-thickness skin grafting for reconstruction
  • Willingness to undergo the study interventions and comply with required study procedures
  • Is a medical and surgical candidate to undergo standard-of-care split-thickness skin graft reconstruction of the penis after standard preoperative optimization

Exclusion Criteria:

  • History of neophallus creation
  • A diagnosed disorder of connective tissue or collagen deposition/formation
  • The inability to obtain sufficient fat from the surgical specimen or separate lipoharvest donor site to allow the autologous fat tissue processing
  • Any medical condition that would preclude safe conduct of the lipoharvest and/or injection procedure per investigator discretion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: STSG Alone
Subjects randomized to this arm of the study will undergo standard-of-care split-thickness skin grafting of their penis without autologous fat grafting. They will undergo the same pre- and post-operative monitoring and complete the same testing as those in the experimental arm of the study.
Subject eligibility for this study is contingent upon a baseline disease process in which subjects require and are appropriate for genitourinary reconstruction with penile split-thickness skin grafting as their surgical standard of care. Patients in both arms will receive the standard of care reconstruction and split-thickness skin grafting. The donor site for the split-thickness skin graft with be at the discretion of the operating surgeon during the case and will not be affected by enrollment and/or allocation within the trial.
Experimental: STSG with Autologous Fat Grafting
Subjects randomized to this arm of the study will undergo standard-of-care split-thickness skin grafting of their penis with autologous fat grafting. For subjects from whom a sufficient quantity of healthy adipose tissue is excised as part of the standard-of-care reconstructive surgery they have elected to undergo, the autologous fat graft will be processed from this specimen and placed between the skin graft and fascia of the penis. For subjects from whom a sufficient quantity of healthy adipose tissue is not excised as part of their standard-of-care reconstructive surgery, lipoaspiration (liposuction) will be performed to harvest fatty tissue that will subsequently undergo minimal processing for grafting.
Subject eligibility for this study is contingent upon a baseline disease process in which subjects require and are appropriate for genitourinary reconstruction with penile split-thickness skin grafting as their surgical standard of care. Patients in both arms will receive the standard of care reconstruction and split-thickness skin grafting. The donor site for the split-thickness skin graft with be at the discretion of the operating surgeon during the case and will not be affected by enrollment and/or allocation within the trial.
In this intervention, subjects will undergo their standard-of-care reconstructive urologic surgery with penile split-thickness skin grafting as medically indicated for treatment of their underline penile/genitourinary condition(s). In addition to this reconstruction, autologous fat grafting will be performed beneath their penile skin graft. For subjects from whom a sufficient quantity of healthy adipose tissue is excised as part of the standard-of-care reconstructive surgery they have elected to undergo, the autologous fat graft will be processed from this specimen and placed between the skin graft and fascia of the penis. For subjects from whom a sufficient quantity of healthy adipose tissue is not excised as part of their standard-of-care reconstructive surgery, lipoaspiration (liposuction) will be performed to harvest fatty tissue that will subsequently undergo minimal processing for grafting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Penile Tissue Pliability
Time Frame: 3 and 12 months postoperatively
The primary outcome of this study will be cutometric assessment of penile tissue pliability following split-thickness skin grafting. This will be measured using established noninvasive, nondestructive techniques that are not expected to cause significant discomfort or distress to patients. The numeric outcome of this, as measured in millimeters, will be directly compared between the experimental and active comparator arms. More pliability is manifested as increased pliability, as measured in millimeters.
3 and 12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual Function
Time Frame: Preoperatively, 3 months postoperatively, and 12 months postoperatively
Subjects' postoperative sexual satisfaction and sexual function will be assessed using the 15-question validated International Index of Erectile Function questionnaire. Pre- and post-operative total scores (measured on a scale of 0 to 45, where a higher score indicates better sexual satisfaction/function) will be compared in a pairwise manner between arms of the study to determine if autologous fat grafting confers increase improvement on IIEF relative to the active comparator arm.
Preoperatively, 3 months postoperatively, and 12 months postoperatively
Urinary Function
Time Frame: Preoperatively, 3 months postoperatively, and 12 months postoperatively
The Internatonal Prostate Symptom Score (IPSS) validated patient questionnaire will be utilized to assess subjects' satisfaction with their urinary function. This questionnaire includes seven Likert-style questions assessing seven domains of urinary function, where a composite score of 0 represents no symptoms and a composite score of 35 represents maximum symptom burden. The questionnaire also contains one additional quality-of-life question, in which 0 represents maximum aggregate satisfaction with urinary function and 6 represents the worst possible satisfaction with urinary function. The pre- and post-operative scores will be analyzed in a pairwise manner, and the change in scores will be assess between the experimental and active comparator groups.
Preoperatively, 3 months postoperatively, and 12 months postoperatively
Genital Self-Image
Time Frame: Preoperatively, 3 months postoperatively, 12 months postoperatively
Subjects' pre- and post-operative subjective genital self-image will be assessed using the 7-question validated Male Genital Self-Image Scale (MGSIS) questionnaire. Pre- and post-operative total scores (measured on a scale of 7 to 28, where a higher score represents a more positive self-image) will be compared in a pairwise manner between arms of the study to determine if autologous fat grafting confers increase improvement on MGSIS relative to the active comparator arm.
Preoperatively, 3 months postoperatively, 12 months postoperatively
Safety and Surgical Complications
Time Frame: Immediately postoperatively through 12 months, including in-person visits at 7 days, 4 weeks, 3 months, and 12 months postoperatively. A telephone call will also be initiated 6 months postoperatively.
Patient safety and surgical complications will be closely monitored throughout the convalescence period of the study in the standard manner for their genitourinary reconstruction procedure. Patients will be seen in-person, and contacted via telephone, for assessment of their wounds. At these visits, interval information will be collected to monitor for adverse events, such as graft failure, infection, incisional dehiscence, graft donor site hematoma, and other wound complications. All adverse events will be scored using the Clavien-Dindo classification system, and classified as minor (Clavien-Dindo 1-2) and major (Clavien-Dindo 3-5). The frequency of major and minor complications in the experimental arm will be compared to the frequency in the active comparator arm.
Immediately postoperatively through 12 months, including in-person visits at 7 days, 4 weeks, 3 months, and 12 months postoperatively. A telephone call will also be initiated 6 months postoperatively.
Stretched Penile Length
Time Frame: Intraoperatively, 3 months postoperatively, 12 months postoperatively
Stretched penile length and associated tissue mobility will be measured and recorded. Average stretched postoperative penile length in the experimental group, as measured in centimeters, will be measured relative to that in the active comparator arm.
Intraoperatively, 3 months postoperatively, 12 months postoperatively
Penile Pain and Sensitivity to Monofilament Testing
Time Frame: 3 and 12 months postoperatively
Penile pain and sensitivity assessment will be performed using standardized protocols for grafting on other areas of the body. These noninvasive methods provide a subjective readout of pain and sensitivity. Specifically, the Semmes Weinstein monofilament test will be used to identify the pressure threshold at which perceptible sensation can be elicited with closed eyes. This is scored on a scale of 1.65-6.65 based on the monofilament sizes within the standard kit. Patients with lower numbers, indicating a smaller monofilament/less pressure can elicit a perceptible response, have greater sensitivity than those with higher numbers. If pain is elicited, they will also be assigned a score on the scale listed above, with a lower score suggestive of lower pain threshold. This will be assessed on the right lateral aspect of the penis, left lateral aspect of the penis, and glans.
3 and 12 months postoperatively
Penile Sensitivity to Two-Point Discrimination Testing
Time Frame: 3 and 12 months postoperatively
The sensitivity of the grafted penile skin will be assessed using the static two-point discrimination test, which is a commonly used test for skin sensitivity testing. In this test, a pair of calipers will be used to determine the spacing at which the patient can detect two discrete points of pressure, as measured in millimeters. A larger distance suggests less sensitivity, while a shorter distance suggests more sensitivity. This will be assessed on the right lateral aspect of the penis, left lateral aspect of the penis, and glans.
3 and 12 months postoperatively
Penile Graft Elasticity
Time Frame: 3 and 12 months postoperatively
Penile graft elasticity will be assessed using noninvasive skin tensiometry. The outcome of this, as measured in mm, will be compared between the experimental and active comparator groups.
3 and 12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul J Rusilko, DO, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Study Registration Dates

First Submitted

November 26, 2025

First Submitted That Met QC Criteria

December 18, 2025

First Posted (Actual)

January 5, 2026

Study Record Updates

Last Update Posted (Actual)

May 5, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY25050015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect the privacy of patients involved in this study, we do not plan on sharing IPD.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Penis/Surgery

Clinical Trials on Genitourinary Reconstruction with Split-Thickness Skin Grafting

Subscribe